scholarly article | Q13442814 |
P50 | author | Douglas N. Greve | Q29642717 |
Anders M. Dale | Q57693390 | ||
Deborah Blacker | Q66816378 | ||
Marilyn S. Albert | Q56861968 | ||
P2093 | author name string | Reisa A Sperling | |
Chantal E Stern | |||
Monika Atiya | |||
Bradford C Dickerson | |||
David H Salat | |||
Ronald J Killiany | |||
Julianna F Bates | |||
P2860 | cites work | Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials | Q22253054 |
“Mini-mental state” | Q25938989 | ||
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
The underpinnings of the BOLD functional magnetic resonance imaging signal | Q28206123 | ||
Alzheimer's disease is a synaptic failure | Q29547670 | ||
Sources of distortion in functional MRI data. | Q30582744 | ||
Scanning patients with tasks they can perform. | Q30582749 | ||
Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging | Q33194494 | ||
Patterns of brain activation in people at risk for Alzheimer's disease. | Q33700984 | ||
Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles | Q33792982 | ||
Functional MRI detection of pharmacologically induced memory impairment | Q33898082 | ||
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease | Q33955976 | ||
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease | Q35470700 | ||
Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies | Q35570834 | ||
Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation | Q35593109 | ||
Preclinical prediction of AD using neuropsychological tests | Q74220290 | ||
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease | Q35677208 | ||
Calibrated functional MRI: mapping the dynamics of oxidative metabolism | Q35892841 | ||
Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space | Q36744339 | ||
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment | Q37313709 | ||
Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients | Q37348015 | ||
The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. | Q37414287 | ||
Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. | Q38430049 | ||
Prefrontal-temporal circuitry for episodic encoding and subsequent memory. | Q38444049 | ||
The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and alzheimer disease | Q38446382 | ||
Dissociable human perirhinal, hippocampal, and parahippocampal roles during verbal encoding. | Q39172132 | ||
Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease | Q40766817 | ||
Preclinical prediction of Alzheimer's disease using SPECT. | Q40854656 | ||
Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. | Q42444929 | ||
Hippocampal formation glucose metabolism and volume losses in MCI and AD. | Q43668221 | ||
Compromised hemodynamic response in amyloid precursor protein transgenic mice. | Q44102454 | ||
MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease | Q44553615 | ||
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment | Q48146954 | ||
Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease | Q48231832 | ||
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice | Q48242315 | ||
Building memories: remembering and forgetting of verbal experiences as predicted by brain activity | Q48407763 | ||
Making memories: brain activity that predicts how well visual experience will be remembered | Q48407772 | ||
Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and nonverbal memory encoding | Q48453521 | ||
Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response | Q48490731 | ||
Women at risk for AD show increased parietal activation during a fluency task | Q48623795 | ||
Image distortion correction in fMRI: A quantitative evaluation | Q48624401 | ||
Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder | Q48647459 | ||
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease | Q48713862 | ||
Encoding novel face-name associations: a functional MRI study | Q48789397 | ||
Dissociation of regional activation in mild AD during visual encoding: a functional MRI study | Q48795287 | ||
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. | Q48963534 | ||
Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment | Q48970270 | ||
Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease | Q49103532 | ||
Estimation and detection of event-related fMRI signals with temporally correlated noise: a statistically efficient and unbiased approach | Q49109951 | ||
Functional MR imaging in Alzheimer's disease during memory encoding. | Q49162668 | ||
Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. | Q52027283 | ||
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. | Q52027757 | ||
Memory and MRI-based hippocampal volumes in aging and AD. | Q52029123 | ||
A new clinical scale for the staging of dementia. | Q52220854 | ||
Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. | Q53208979 | ||
Functional brain imaging of young, nondemented, and demented older adults. | Q53243570 | ||
Predicting conversion to Alzheimer disease using standardized clinical information. | Q53340763 | ||
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. | Q53350823 | ||
P433 | issue | 1 | |
P921 | main subject | mild cognitive impairment | Q1472703 |
cognitive dysfunction | Q57859955 | ||
P304 | page(s) | 27-35 | |
P577 | publication date | 2004-07-01 | |
P1433 | published in | Annals of Neurology | Q564414 |
P1476 | title | Medial temporal lobe function and structure in mild cognitive impairment | |
P478 | volume | 56 |
Q40833611 | A Meta-Analysis of fMRI Activation Differences during Episodic Memory in Alzheimer's Disease and Mild Cognitive Impairment |
Q39044983 | A family of locally constrained CCA models for detecting activation patterns in fMRI. |
Q31147684 | A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease |
Q33812303 | A protocol for manual segmentation of medial temporal lobe subregions in 7 Tesla MRI. |
Q64080813 | A study on changes of the resting-state brain function network in patients with amnestic mild cognitive impairment |
Q41496810 | A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease. |
Q56333867 | APOE ε4 status in healthy older African Americans is associated with deficits in pattern separation and hippocampal hyperactivation |
Q33423191 | APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging |
Q33832181 | ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia |
Q35597131 | Aberrant default mode network in subjects with amnestic mild cognitive impairment using resting-state functional MRI. |
Q36799532 | Abnormal Population Responses in the Somatosensory Cortex of Alzheimer's Disease Model Mice |
Q33834758 | Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment |
Q37064559 | Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment |
Q30870223 | Advances in MRI biomarkers for the diagnosis of Alzheimer's disease |
Q31117150 | Advances in functional magnetic resonance imaging: technology and clinical applications |
Q37375989 | Age-related alterations in simple declarative memory and the effect of negative stimulus valence |
Q84022628 | Age-related changes in visually evoked electrical brain activity |
Q36883144 | Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation |
Q33854767 | Age-related shifts in brain activity dynamics during task switching |
Q37707104 | Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors |
Q51978821 | Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. |
Q37165672 | Altered fMRI activation during mental rotation in those at genetic risk for Alzheimer disease. |
Q48856161 | Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study |
Q27001223 | Alternative neural circuitry that might be impaired in the development of Alzheimer disease |
Q36368439 | Alzheimer risk variant CLU and brain function during aging |
Q60451955 | Amyloid Deposition Is Associated with Different Patterns of Hippocampal Connectivity in Men versus Women |
Q33599047 | Amyloid burden and neural function in people at risk for Alzheimer's Disease |
Q37335603 | Amyloid deposition is associated with impaired default network function in older persons without dementia |
Q35626520 | Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression |
Q37020997 | An MRI study of age-related white and gray matter volume changes in the rhesus monkey |
Q34095084 | An abnormal resting-state functional brain network indicates progression towards Alzheimer's disease. |
Q37219729 | An entorhinal cortex sulcal pattern is associated with Alzheimer's disease |
Q40108975 | An evaluation of distinct volumetric and functional MRI contributions toward understanding age and task performance: a study in the basal ganglia |
Q36466486 | Analysis of grey matter in thalamus and basal ganglia based on EEG α3/α2 frequency ratio reveals specific changes in subjects with mild cognitive impairment |
Q37855550 | Anatomical Substrate and Scalp EEG Markers are Correlated in Subjects with Cognitive Impairment and Alzheimer's Disease |
Q34154541 | Anatomical and functional deficits in patients with amnestic mild cognitive impairment |
Q57490762 | Apolipoprotein E ε4 Specifically Modulates the Hippocampus Functional Connectivity Network in Patients With Amnestic Mild Cognitive Impairment |
Q34251259 | Assessing corpus callosum changes in Alzheimer's disease: comparison between tract-based spatial statistics and atlas-based tractography |
Q36237896 | Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study |
Q36033650 | Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele |
Q37104976 | Associative learning over trials activates the hippocampus in healthy elderly but not mild cognitive impairment |
Q33822960 | Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment |
Q37003190 | Baseline blood oxygenation modulates response amplitude: Physiologic basis for intersubject variations in functional MRI signals |
Q38797428 | Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease |
Q31050728 | Biomarkers in the diagnosis of Alzheimer's disease: are we ready? |
Q24650667 | Biomarkers of Alzheimer's disease |
Q47983510 | Both hyper- and hypo-activation to cognitive challenge are associated with increased beta-amyloid deposition in healthy aging: A nonlinear effect |
Q35561052 | Brain activation during working memory is altered in patients with type 1 diabetes during hypoglycemia |
Q36098588 | Brain aging: reorganizing discoveries about the aging mind |
Q48265048 | Brain functional connectivity in lung cancer population: an exploratory study |
Q26996299 | Brain imaging in Alzheimer disease |
Q34102331 | Brain imaging in the study of Alzheimer's disease |
Q30849637 | Brain imaging of mild cognitive impairment and Alzheimer's disease |
Q31066988 | Brain imaging of neurovascular dysfunction in Alzheimer's disease |
Q64950892 | Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography. |
Q31065297 | Brain profile of hypometabolism in early Alzheimer's disease: relationships with cognitive deficits and atrophy |
Q34441879 | Brain-derived neurotrophic factor val66met polymorphism and hippocampal activation during episodic encoding and retrieval tasks |
Q37678549 | Bridging neurocognitive aging and disease modification: targeting functional mechanisms of memory impairment |
Q30884744 | Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment? |
Q33769371 | Capturing heterogeneous group differences using mixture-of-experts: Application to a study of aging |
Q39410816 | Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review. |
Q50082178 | Chronic whiplash symptoms are related to altered regional cerebral blood flow in the resting state |
Q30586728 | Clinical applications and future directions of functional MRI. |
Q36969034 | Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment |
Q34084426 | Cognitive correlates of metamemory in Alzheimer's disease |
Q48285672 | Comparative study of regional homogeneity in schizophrenia and major depressive disorder |
Q35113276 | Computational models of the hippocampal region: implications for prediction of risk for Alzheimer's disease in non-demented elderly. |
Q31150981 | Concept of functional imaging of memory decline in Alzheimer's disease |
Q24629087 | Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment |
Q30722226 | Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data |
Q52568314 | Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease. |
Q36152533 | Default mode network functional connectivity: a promising biomarker for diagnosing minimal hepatic encephalopathy: CONSORT-compliant article |
Q35994372 | Dementia: finding the signals in the noise |
Q64231688 | Development of a Stand-Alone Independent Graphical User Interface for Neurological Disease Prediction with Automated Extraction and Segmentation of Gray and White Matter in Brain MRI Images |
Q40050006 | Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment |
Q36256485 | Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease |
Q37074586 | Distinct hippocampal regions make unique contributions to relational memory |
Q37248729 | Distinct medial temporal contributions to different forms of recognition in amnestic mild cognitive impairment and Alzheimer's disease. |
Q48758156 | EEG markers discriminate among different subgroup of patients with mild cognitive impairment. |
Q36607324 | Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there? |
Q37115603 | Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults |
Q34390983 | Effect of acupuncture in mild cognitive impairment and Alzheimer disease: a functional MRI study |
Q34517029 | Effects of apolipoprotein E genotype on the off-line memory consolidation |
Q37177003 | Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. |
Q49843041 | Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment: a critical review |
Q34691589 | Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task. |
Q47229656 | Elevated Markers of Inflammation Are Associated With Longitudinal Changes in Brain Function in Older Adults |
Q33605714 | Emotional blunting following left basal ganglia stroke: the role of depression and fronto-limbic functional alterations. |
Q48408150 | Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years |
Q35190344 | Entorhinal cortex volume is associated with episodic memory related brain activation in normal aging and amnesic mild cognitive impairment |
Q50962766 | Event-related potentials elicited by face identity processing in elderly adults with cognitive impairment. |
Q92255306 | Evidence of parietal hyperactivation in individuals with mild cognitive impairment who progressed to dementia: A longitudinal fMRI study |
Q91800387 | Executive task-based brain function in children with type 1 diabetes: An observational study |
Q37348964 | Familial risk for Alzheimer's disease alters fMRI activation patterns. |
Q38428341 | Frontoparietal cognitive control of verbal memory recall in Alzheimer's disease |
Q31065291 | Functional MRI in the early detection of dementias |
Q34378779 | Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease |
Q31108283 | Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease |
Q31143202 | Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies |
Q34565270 | Functional alterations in memory networks in early Alzheimer's disease |
Q36729474 | Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia |
Q37388579 | Functional magnetic resonance imaging changes in amnestic and nonamnestic mild cognitive impairment during encoding and recognition tasks |
Q33393603 | Functional magnetic resonance imaging of compensatory neural recruitment in aging and risk for Alzheimer's disease: review and recommendations |
Q81651025 | Functional neuroimaging of cognition |
Q36323358 | Functional reorganization in obstructive sleep apnoea and insomnia: A systematic review of the resting-state fMRI. |
Q34415697 | Functional response in ventral temporal cortex differentiates mild cognitive impairment from normal aging. |
Q31162702 | Future Directions in Imaging Neurodegeneration |
Q34017939 | High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment |
Q37194883 | Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline |
Q36227167 | Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding |
Q37665949 | Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline. |
Q30496699 | Hippocampal activity during the transverse patterning task declines with cognitive competence but not with age. |
Q35787932 | Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults |
Q35218523 | Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease |
Q51013250 | Hyperactivation of parahippocampal region and fusiform gyrus associated with successful encoding in medial temporal lobe epilepsy. |
Q35560436 | Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics |
Q93265075 | Imaging biomarkers in neurodegeneration: current and future practices |
Q38169551 | Imaging markers of structural and functional brain changes that precede cognitive symptoms in risk for Alzheimer's disease |
Q41698774 | Incipient preoperative reorganization processes of verbal memory functions in patients with left temporal lobe epilepsy. |
Q37567356 | Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment. |
Q35105340 | Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD |
Q35181687 | Independent component analysis-based identification of covariance patterns of microstructural white matter damage in Alzheimer's disease |
Q34014704 | Interaction of age and APOE genotype on cerebral blood flow at rest. |
Q50558815 | Investigating Associative Learning Effects in Patients with Prodromal Alzheimer's Disease Using the Temporal Context Model. |
Q33511725 | Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging |
Q48112974 | Learning to predict is spared in mild cognitive impairment due to Alzheimer's disease. |
Q35197404 | Less wiring, more firing: low-performing older adults compensate for impaired white matter with greater neural activity. |
Q35510426 | Lifespan brain activity, β-amyloid, and Alzheimer's disease |
Q34002796 | Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline |
Q36304533 | MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults |
Q31152538 | Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review |
Q36257224 | Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease |
Q57285538 | Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing |
Q34622731 | Medial temporal lobe function during emotional memory in early Alzheimer's disease, mild cognitive impairment and healthy ageing: an fMRI study |
Q30827725 | Mild Cognitive Impairment Is Not "Mild" at All in Altered Activation of Episodic Memory Brain Networks: Evidence from ALE Meta-Analysis |
Q26786539 | Mild Neurocognitive Disorder: An Old Wine in a New Bottle |
Q26795498 | Mild cognitive impairment and fMRI studies of brain functional connectivity: the state of the art |
Q35236843 | Mild cognitive impairment: historical development and summary of research |
Q46785813 | Mild cognitive impairment: to treat or not to treat |
Q53390130 | Model-free group analysis shows altered BOLD FMRI networks in dementia. |
Q27021454 | Molecular aspects of age-related cognitive decline: the role of GABA signaling |
Q38796950 | Network abnormalities and interneuron dysfunction in Alzheimer disease |
Q51037362 | Network interactions explain effective encoding in the context of medial temporal damage in MCI. |
Q90356990 | Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease |
Q27023864 | Network-based biomarkers in Alzheimer's disease: review and future directions |
Q34038444 | Neural Correlates of Unsuccessful Memory Performance in MCI. |
Q34253028 | Neural compensation in older people with brain amyloid-β deposition |
Q30425315 | Neuroanatomical substrates of age-related cognitive decline |
Q29614723 | Neurodegenerative diseases target large-scale human brain networks |
Q30989943 | Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease |
Q30051683 | Neuroimaging of individuals with Down’s syndrome at-risk for dementia: Evidence for possible compensatory events |
Q35485230 | Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. |
Q38536860 | Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function |
Q36449520 | Olfactory deficit detected by fMRI in early Alzheimer's disease |
Q51928085 | One month of human memory consolidation enhances retrieval-related hippocampal activity. |
Q34995948 | P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway |
Q34441691 | Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults |
Q30586952 | Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease. |
Q37412240 | Physical exercise and cognitive performance in the elderly: current perspectives |
Q37077931 | Pomegranate juice augments memory and FMRI activity in middle-aged and older adults with mild memory complaints. |
Q41726391 | Posterior compensatory network in cognitively intact elders with hippocampal atrophy |
Q35513638 | Posteromedial hyperactivation during episodic recognition among people with memory decline: findings from the WRAP study. |
Q26864734 | Potential of functional MRI as a biomarker in early Alzheimer's disease |
Q34444109 | Preclinical Alzheimer's disease: diagnosis and prediction of progression |
Q37335585 | Predicting the location of entorhinal cortex from MRI. |
Q36580643 | Prefrontal contributions to relational encoding in amnestic mild cognitive impairment |
Q37337857 | Prefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: an event-related functional-anatomic MRI study |
Q36234023 | Preserved and impaired emotional memory in Alzheimer's disease |
Q28088701 | Preventing Alzheimer's disease by means of natural selection |
Q33304443 | Prognostic value of posteromedial cortex deactivation in mild cognitive impairment |
Q33938940 | Prominent hippocampal CA3 gene expression profile in neurocognitive aging |
Q98165184 | Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo |
Q36140952 | Quantitative EEG Markers in Mild Cognitive Impairment: Degenerative versus Vascular Brain Impairment |
Q37596431 | Quantitative evaluation of Alzheimer's disease |
Q90142767 | Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder |
Q35677207 | Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease. |
Q34551727 | Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2 |
Q35957965 | Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment |
Q36582762 | Regional cerebral blood flow reductions, heart failure and Alzheimer's disease. |
Q35091417 | Regional homogeneity changes in hemodialysis patients with end stage renal disease: in vivo resting-state functional MRI study |
Q47969696 | Relationship of Lutein and Zeaxanthin Levels to Neurocognitive Functioning: An fMRI Study of Older Adults |
Q36551535 | Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults |
Q36243393 | Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment |
Q48451289 | Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease. |
Q35908435 | Simultaneous changes in gray matter volume and white matter fractional anisotropy in Alzheimer's disease revealed by multimodal CCA and joint ICA. |
Q36226953 | Single photon emission computed tomography perfusion differences in mild cognitive impairment |
Q31122548 | Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging |
Q48715289 | Spontaneous brain activity in mild cognitive impairment revealed by amplitude of low-frequency fluctuation analysis: a resting-state fMRI study. |
Q33556006 | Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions |
Q28085612 | Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives |
Q33967561 | Structural imaging in early pre-states of dementia |
Q89971040 | Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment |
Q49144558 | Structure and function of medial temporal and posteromedial cortices in early Alzheimer's disease |
Q35154239 | Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment |
Q37114077 | Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease. |
Q39339952 | Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease |
Q33940338 | Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers |
Q35793076 | Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials |
Q24647259 | The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods |
Q91588034 | The Consortium for the early identification of Alzheimer's disease-Quebec (CIMA-Q) |
Q35612579 | The Effects of Acupuncture at Real or Sham Acupoints on the Intrinsic Brain Activity in Mild Cognitive Impairment Patients. |
Q33387373 | The adaptive brain: aging and neurocognitive scaffolding |
Q38016800 | The development of effective biomarkers for Alzheimer's disease: a review |
Q91336931 | The effect of white matter signal abnormalities on default mode network connectivity in mild cognitive impairment |
Q34989708 | The effects of age on resting state functional connectivity of the basal ganglia from young to middle adulthood. |
Q37198894 | The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation |
Q48461383 | The influence of age and mild cognitive impairment on associative memory performance and underlying brain networks |
Q37300271 | The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. |
Q30426047 | The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease |
Q37087193 | The relationship between aging, performance, and the neural correlates of successful memory encoding |
Q31094049 | The role of neuroimaging in elucidating delirium pathophysiology |
Q48439610 | Topographical recognition memory sensitive to amnestic mild cognitive impairment but not to depression |
Q33281339 | Tracking Alzheimer's disease |
Q33419370 | Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease |
Q33645744 | Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment |
Q51968962 | Understanding medial temporal activation in memory tasks: evidence from fMRI of encoding and recognition in a case of transient global amnesia. |
Q34611682 | Use of a modified spatial-context memory test to detect amnestic mild cognitive impairment |
Q31111440 | Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease |
Q27014791 | Ushering in the study and treatment of preclinical Alzheimer disease |
Q36576426 | Vascular changes and brain plasticity: a new approach to neurodegenerative diseases. |
Q34245836 | Vascular health risks and fMRI activation during a memory task in older adults |
Q35230612 | Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response |
Q41623625 | Visualizing Hyperactivation in Neurodegeneration Based on Prefrontal Oxygenation: A Comparative Study of Mild Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls |
Q36573616 | Vulnerable neural systems and the borderland of brain aging and neurodegeneration |
Q39344710 | Your perspective and my benefit: multiple lesion models of self-other integration strategies during social bargaining |
Q51978705 | [Alzheimer's disease and human memory] |
Q37383230 | fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults |
Q30496761 | fMRI congruous word repetition effects reflect memory variability in normal elderly |
Q57911678 | fMRI in Neurodegenerative Diseases: From Scientific Insights to Clinical Applications |
Search more.